Lp-PLA2-IN-13
Lp-PLA2-IN-13 (compound 15) is a potent Lp-PLA2 inhibitor. Lp-PLA2-IN-13 has the potential for the research of neurodegenerative related diseases[1].
Product Specifications
CAS Number
[2756855-62-4]
UNSPSC
12352005
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lp-pla2-in-13.html
Purity
99.95
Solubility
10 mM in DMSO
Smiles
O=C1N=C(C2=C(N1CCC3)N3CCO2)OCC4=CC(F)=C(C(F)=C4)OC5=CC(C(F)(F)F)=NC=C5
Molecular Formula
C22H17F5N4O4
Molecular Weight
496.39
References & Citations
[1]ZhengHua Gu, et al. Tricyclic pyrimidone compounds, preparation method, composition and application thereof. CN113861220A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
351134-01 50 µg
CCNG1, Recombinant, Human, aa1-295, His-Tag (Cyclin-G1, CCNG, CYCG1)
Ask
View Details 351134-02 250 µg
CCNG1, Recombinant, Human, aa1-295, His-Tag (Cyclin-G1, CCNG, CYCG1)
Ask
View Details 